Indicators

Latest News about Multidisciplinary Association for Psychedelic Studies

Recent news which mentions Multidisciplinary Association for Psychedelic Studies

FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays

November 20, 2024

Massachusetts Votes Down Psychedelic Therapy After Hard-Fought Legalization Campaign, What's Next?

November 06, 2024

FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care

October 31, 2024

Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy

September 11, 2024

Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD

August 29, 2024

How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare

June 24, 2024

MDMA Therapy For PTSD Closer To Legality As Key FDA Approval Meeting Approaches, Sparking Hope And Controversy

June 03, 2024

Meet Oregon's Legal Psilocybin Retreats Powered By NASA And Ivy League Talent

February 16, 2024

NFL's Jon Feliciano Takes His Psychedelics Advocacy To The Field: Chooses MAPS As His "My Cleats, My Cause"

December 05, 2023

Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News

September 15, 2023

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

July 04, 2023

Burning Man CEO Learned 'So Much' About Psychedelics In BRC: 'We're Here For The Love'

June 30, 2023

World's Largest Psychedelics Conference Sheds Light On Alternative Mental Health Therapies, Boasts 12K Attendees

June 26, 2023

Psychedelic Science 101: Dr. Huberman Calls On Academics To Have 'The Guts To Take On Something Risky'

June 22, 2023

MAPS' Psychedelic Science 2023: Gov. Polis To Open Event, New Shulgin Compounds To Be Revealed

June 14, 2023

The Flaming Lips, Eric Andre & Reggie Watts And Many More At MAPS 2023 Psychedelic Event

May 18, 2023

MDMA Therapy For PTSD Nearing Legalization In US And Worldwide, MAPS Releases Promising Data

April 05, 2023

Psychedelic Science 2023: Details On Agenda And Acclaimed Speakers At MAPS Annual Gathering

March 10, 2023

Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers

January 30, 2023

Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund

October 12, 2022

MAPS Gets A New Partner To Study MDMA Therapy In Patients With PTSD

September 14, 2022

Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say

May 20, 2022

Ecstasy Research Trial Completes Enrollment, Moves Closer To Approval To Treat PTSD

May 10, 2022

DEA Under Fire For Blocking Psilocybin As Treatment For Terminally Ill Cancer Patients

April 14, 2022

Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS

March 30, 2022

Psychedelic Companies Keenly Aware Of Creating Therapies As Healthcare Reimbursement Possibility Looms

November 22, 2021

Australian Psychiatrist Sues State Of Victoria For Denying MDMA Treatment For Ailing Patient

November 17, 2021

Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics

September 17, 2021

Can MDMA Treat Traumatic Brain Injury? $1.5 Million Are Being Committed To Finding Out

September 14, 2021

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.